Phage therapy: the Escherichia coli experience
- 1 July 2005
- journal article
- review article
- Published by Microbiology Society in Microbiology
- Vol. 151 (7) , 2133-2140
- https://doi.org/10.1099/mic.0.27849-0
Abstract
Phages have been proposed as natural antimicrobial agents to fight bacterial infections in humans, in animals or in crops of agricultural importance. Phages have also been discussed as hygiene measures in food production facilities and hospitals. These proposals have a long history, but are currently going through a kind of renaissance as documented by a spate of recent reviews. This review discusses the potential of phage therapy with a specific example, namelyEscherichia coli.Keywords
This publication has 80 references indexed in Scilit:
- Human Volunteers Receiving Escherichia coli Phage T4 Orally: a Safety Test of Phage TherapyAntimicrobial Agents and Chemotherapy, 2005
- Bacteriophages show promise as antimicrobial agentsPublished by Elsevier ,2004
- Phages and the Evolution of Bacterial Pathogens: from Genomic Rearrangements to Lysogenic ConversionMicrobiology and Molecular Biology Reviews, 2004
- Experimental Examination of BacteriophageLatent-Period Evolution as a Response to BacterialAvailabilityApplied and Environmental Microbiology, 2003
- Common themes among bacteriophage-encoded virulence factors and diversity among the bacteriophages involvedPublished by Elsevier ,2002
- Antagonistic coevolution between a bacterium and a bacteriophageProceedings Of The Royal Society B-Biological Sciences, 2002
- Linking genetic change to community evolution: insights from studies of bacteria and bacteriophageEcology Letters, 2000
- A catalogue of T4-type bacteriophagesArchiv für die gesamte Virusforschung, 1997
- A bacterial virulence determinant encoded by lysogenic coliphage λNature, 1990
- Epidemiology of Travelers' Diarrhea and Relative Importance of Various PathogensClinical Infectious Diseases, 1990